List view / Grid view
16 January 2017 | By Mettler Toledo
METTLER TOLEDO’s firmware version 2.20 for its Excellence Moisture Analyzers HX204 and HS153 allows individual methods assignment to ensure users follow SOPs and avoid mistakes. This added level of security saves time and helps to eliminate costly rework...
16 January 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has extended the review period for Eli Lilly and Incyte’s new drug application for investigational baricitinib, a once-daily oral medication for the treatment of moderate to severe rheumatoid arthritis (RA).
12 January 2017 | By Niamh Marriott, Digital Editor
This product is a proposed biosimilar to branded trastuzumab, which is indicated to treat certain HER2-positive breast cancers...
12 January 2017 | By Niamh Marriott, Digital Editor
Topline results from this Phase IIb study to treat children with RSV with inhaled ALX-0171 are expected in the second half of 2018...
12 January 2017 | By Niamh Marriott, Digital Editor
More than 100 prominent life sciences executives, investors, and business leaders have signed an open letter calling on the industry to increase gender diversity...
12 January 2017 | By Niamh Marriott, Digital Editor
Everolimus (Afinitor, Novartis) is now recommended to be available on the NHS as a treatment option for some patients with advanced renal cell carcinoma...
11 January 2017 | By Niamh Marriott, Digital Editor
F901318 is the first member of a novel class of systemic antifungal agents targeting life threatening mould infections and acting through a target...
11 January 2017 | By Niamh Marriott, Digital Editor
The NHS Confederation today announced the appointment of Niall Dickson as its new Chief Executive.
10 January 2017 | By Dolomite Bio
Dolomite Bio has launched a new Injection Valve and Sample Loop for single cell RNA sequencing workflows...
10 January 2017 | By Charles Ischi AG | Kraemer Elektronik
EPM talks to Charles Ischi about the best approach to selecting testing equipment for oral solid dosage applications...
10 January 2017 | By Niamh Marriott, Digital Editor
Novartis announced a collaboration and option agreement with Ionis Pharmaceuticals and its affiliate Akcea Therapeutics to license two novel treatments with the potential to significantly reduce cardiovascular risk in patients suffering from high levels of lipoproteins known as Lp(a) and ApoCIII.
10 January 2017 | By Niamh Marriott, Digital Editor
The blood test produces standardised results for assessing ovarian reserve as compared with the use of vaginal ultrasound...
9 January 2017 | By Niamh Marriott, Digital Editor
AR-301 (Salvecin) is a fully human monoclonal IgG1 antibody that specifically targets S. aureus alpha-toxin and protects host cells from destruction...
5 January 2017 | By Niamh Marriott, Digital Editor
Amorsa has announced a research, option and license agreement with Janssen to develop and commercialise a novel small molecule drug candidate for depression...
5 January 2017 | By Niamh Marriott, Digital Editor
In the trial, empagliflozin significantly reduced the relative risk of the combined primary endpoint of cardiovascular death, non-fatal heart attack by 14%...
